STROBE checklists

1，用于队列研究，病例对照研究和横断面研究的STROBE清单（组合）；2，用于队列研究，病例对照研究和横断面研究的STROBE清单； 3，同类研究清单；4，病例对照研究清单；5，横断面研究清单；6，会议摘要的STROBE清单清单草稿。STROBE_checklist_case-controlSTROBE Statement—Checklist of items thatshould be included in reports of case-control studiesItem NoRecommendationTitle and abstract1(a) Indicate the study’s design with a commonly used term in the title or the abstract(b) Provide in the abstract an informative and balanced summary of what was done and what was foundIntroductionBackground/rationale2Explain the scientific background and rationale for the investigation being reportedObjectives3State specific objectives, including any prespecified hypothesesMethodsStudy design4Present key elements of study design early in the paperSetting5Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collectionParticipants6(a) Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls(b) For matched studies, give matching criteria and the number of controls per caseVariables7Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicableData sources/ measurement8*For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one groupBias9Describe any efforts to address potential sources of biasStudy size10Explain how the study size was arrived atQuantitative variables11Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and whyStatistical methods12(a) Describe all statistical methods, including those used to control for confounding(b) Describe any methods used to examine subgroups and interactions(c) Explain how missing data were addressed(d) If applicable, explain how matching of cases and controls was addressed(e) Describe any sensitivity analysesResultsParticipants13*(a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed(b) Give reasons for non-participation at each stage(c) Consider use of a flow diagramDescriptive data14*(a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders(b) Indicate number of participants with missing data for each variable of interestOutcome data15*Report numbers in each exposure category, or summary measures of exposureMain results16(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included(b) Report category boundaries when continuous variables were categorized(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time periodOther analyses17Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analysesDiscussionKey results18Summarise key results with reference to study objectivesLimitations19Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential biasInterpretation20Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidenceGeneralisability21Discuss the generalisability (external validity) of the study resultsOther informationFunding22Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based*Give information separately for cases andcontrols.Note: An Explanation and Elaboration articlediscusses each checklist item and gives methodological background and publishedexamples of transparent reporting. The STROBE checklist is best used inconjunction with this article (freely available on the Web sites of PLoSMedicine at http://www.plosmedicine.org/, Annals of Internal Medicine athttp://www.annals.org/, and Epidemiology at http://www.epidem.com/).Information on the STROBE Initiative is available athttp://www.strobe-statement.org.STROBE Statement—Checklist of items that should be included in reports of cohort studiesItem NoRecommendationTitle and abstract1(a) Indicate the study’s design with a commonly used term in the title or the abstract(b) Provide in the abstract an informative and balanced summary of what was done and what was foundIntroductionBackground/rationale2Explain the scientific background and rationale for the investigation being reportedObjectives3State specific objectives, including any prespecified hypothesesMethodsStudy design4Present key elements of study design early in the paperSetting5Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collectionParticipants6(a) Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up(b) For matched studies, give matching criteria and number of exposed and unexposedVariables7Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicableData sources/ measurement8*For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one groupBias9Describe any efforts to address potential sources of biasStudy size10Explain how the study size was arrived atQuantitative variables11Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and whyStatistical methods12(a) Describe all statistical methods, including those used to control for confounding(b) Describe any methods used to examine subgroups and interactions(c) Explain how missing data were addressed(d) If applicable, explain how loss to follow-up was addressed(e) Describe any sensitivity analysesResultsParticipants13*(a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed(b) Give reasons for non-participation at each stage(c) Consider use of a flow diagramDescriptive data14*(a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders(b) Indicate number of participants with missing data for each variable of interest(c) Summarise follow-up time (eg, average and total amount)Outcome data15*Report numbers of outcome events or summary measures over timeMain results16(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included(b) Report category boundaries when continuous variables were categorized(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time periodOther analyses17Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analysesDiscussionKey results18Summarise key results with reference to study objectivesLimitations19Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential biasInterpretation20Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidenceGeneralisability21Discuss the generalisability (external validity) of the study resultsOther informationFunding22Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based*Give information separately for exposed and unexposed groups.Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at http://www.strobe-statement.org.STROBE Statement—checklist of items that should be included in reports of observational studiesItem NoRecommendationTitle and abstract1(a) Indicate the study’s design with a commonly used term in the title or the abstract(b) Provide in the abstract an informative and balanced summary of what was done and what was foundIntroductionBackground/rationale2Explain the scientific background and rationale for the investigation being reportedObjectives3State specific objectives, including any prespecified hypothesesMethodsStudy design4Present key elements of study design early in the paperSetting5Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collectionParticipants6(a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-upCase-control study—Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controlsCross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants(b) Cohort study—For matched studies, give matching criteria and number of exposed and unexposedCase-control study—For matched studies, give matching criteria and the number of controls per caseVariables7Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicableData sources/ measurement8*For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one groupBias9Describe any efforts to address potential sources of biasStudy size10Explain how the study size was arrived atQuantitative variables11Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and whyStatistical methods12(a) Describe all statistical methods, including those used to control for confounding(b) Describe any methods used to examine subgroups and interactions(c) Explain how missing data were addressed(d) Cohort study—If applicable, explain how loss to follow-up was addressedCase-control study—If applicable, explain how matching of cases and controls was addressedCross-sectional study—If applicable, describe analytical methods taking account of sampling strategy(e) Describe any sensitivity analysesContinued on next pageResultsParticipants13*(a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed(b) Give reasons for non-participation at each stage(c) Consider use of a flow diagramDescriptive data14*(a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders(b) Indicate number of participants with missing data for each variable of interest(c) Cohort study—Summarise follow-up time (eg, average and total amount)Outcome data15*Cohort study—Report numbers of outcome events or summary measures over timeCase-control study—Report numbers in each exposure category, or summary measures of exposureCross-sectional study—Report numbers of outcome events or summary measuresMain results16(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included(b) Report category boundaries when continuous variables were categorized(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time periodOther analyses17Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analysesDiscussionKey results18Summarise key results with reference to study objectivesLimitations19Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential biasInterpretation20Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidenceGeneralisability21Discuss the generalisability (external validity) of the study resultsOther informationFunding22Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available atwww.strobe-statement.org.STROBE_checklist_conference_abstract_DRAFT_v03 1 STROBE Statement—Items to be included when reporting observational studies in a conference abstract Item Recommendation Title Indicate the study’s design with a commonly used term in the title (e.g cohort, casecontrol, cross sectional) Authors Contact details for the corresponding author Study design Description of the study design (e.g cohort, case-control, cross sectional) Objective Specific objectives or hypothesis Methods Setting Description of setting, follow-up dates or dates at which the outcome events occurred or at which the outcomes were present, as well as any points or ranges on other time scales for the outcomes (e.g., prevalence at age 18, 1998-2007). Participants Cohort study—Give the most important eligibility criteria, and the most important sources and methods of selection of participants. Describe briefly the methods of follow-up Case-control study—Give the major eligibility criteria, and the major sources and methods of case ascertainment and control selection Cross-sectional study—Give the eligibility criteria, and the major sources and methods of selection of participants Cohort study—For matched studies, give matching and number of exposed and unexposed Case-control study—For matched studies, give matching criteria and the number of controls per case Variables Clearly define primary outcome for this report. Statistical methods Describe statistical methods, including those used to control for confounding Results Participants Report Number of participants at the beginning and end of the study Main results Report estimates of associations. If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period Report appropriate measures of variability and uncertainty (e.g., odds ratios with confidence intervals Conclusions General interpretation of study resultsSTROBE Statement—Checklist of items that should be included in reports of cross-sectional studiesItem NoRecommendationTitle and abstract1(a) Indicate the study’s design with a commonly used term in the title or the abstract(b) Provide in the abstract an informative and balanced summary of what was done and what was foundIntroductionBackground/rationale2Explain the scientific background and rationale for the investigation being reportedObjectives3State specific objectives, including any prespecified hypothesesMethodsStudy design4Present key elements of study design early in the paperSetting5Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collectionParticipants6(a) Give the eligibility criteria, and the sources and methods of selection of participantsVariables7Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicableData sources/ measurement8*For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one groupBias9Describe any efforts to address potential sources of biasStudy size10Explain how the study size was arrived atQuantitative variables11Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and whyStatistical methods12(a) Describe all statistical methods, including those used to control for confounding(b) Describe any methods used to examine subgroups and interactions(c) Explain how missing data were addressed(d) If applicable, describe analytical methods taking account of sampling strategy(e) Describe any sensitivity analysesResultsParticipants13*(a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed(b) Give reasons for non-participation at each stage(c) Consider use of a flow diagramDescriptive data14*(a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders(b) Indicate number of participants with missing data for each variable of interestOutcome data15*Report numbers of outcome events or summary measuresMain results16(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included(b) Report category boundaries when continuous variables were categorized(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time periodOther analyses17Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analysesDiscussionKey results18Summarise key results with reference to study objectivesLimitations19Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential biasInterpretation20Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidenceGeneralisability21Discuss the generalisability (external validity) of the study resultsOther informationFunding22Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based*Give information separately for exposed and unexposed groups.Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available atwww.strobe-statement.org.STROBE Statement—checklist of items that should be included in reports of observational studiesItem NoRecommendationTitle and abstract1(a) Indicate the study’s design with a commonly used term in the title or the abstract(b) Provide in the abstract an informative and balanced summary of what was done and what was foundIntroductionBackground/rationale2Explain the scientific background and rationale for the investigation being reportedObjectives3State specific objectives, including any prespecified hypothesesMethodsStudy design4Present key elements of study design early in the paperSetting5Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collectionParticipants6(a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-upCase-control study—Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controlsCross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants(b) Cohort study—For matched studies, give matching criteria and number of exposed and unexposedCase-control study—For matched studies, give matching criteria and the number of controls per caseVariables7Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicableData sources/ measurement8*For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one groupBias9Describe any efforts to address potential sources of biasStudy size10Explain how the study size was arrived atQuantitative variables11Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and whyStatistical methods12(a) Describe all statistical methods, including those used to control for confounding(b) Describe any methods used to examine subgroups and interactions(c) Explain how missing data were addressed(d) Cohort study—If applicable, explain how loss to follow-up was addressedCase-control study—If applicable, explain how matching of cases and controls was addressedCross-sectional study—If applicable, describe analytical methods taking account of sampling strategy(e) Describe any sensitivity analysesContinued on next pageResultsParticipants13*(a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed(b) Give reasons for non-participation at each stage(c) Consider use of a flow diagramDescriptive data14*(a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders(b) Indicate number of participants with missing data for each variable of interest(c) Cohort study—Summarise follow-up time (eg, average and total amount)Outcome data15*Cohort study—Report numbers of outcome events or summary measures over timeCase-control study—Report numbers in each exposure category, or summary measures of exposureCross-sectional study—Report numbers of outcome events or summary measuresMain results16(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included(b) Report category boundaries when continuous variables were categorized(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time periodOther analyses17Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analysesDiscussionKey results18Summarise key results with reference to study objectivesLimitations19Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential biasInterpretation20Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidenceGeneralisability21Discuss the generalisability (external validity) of the study resultsOther informationFunding22Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.STROBE Statement—checklist of items that should be included in reports of observational studiesItem No.RecommendationPageNo.Relevant text from manuscriptTitle and abstract1(a) Indicate the study’s design with a commonly used term in the title or the abstract(b) Provide in the abstract an informative and balanced summary of what was done and what was foundIntroductionBackground/rationale2Explain the scientific background and rationale for the investigation being reportedObjectives3State specific objectives, including any prespecified hypothesesMethodsStudy design4Present key elements of study design early in the paperSetting5Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collectionParticipants6(a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-upCase-control study—Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controlsCross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants(b) Cohort study—For matched studies, give matching criteria and number of exposed and unexposedCase-control study—For matched studies, give matching criteria and the number of controls per caseVariables7Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicableData sources/ measurement8*For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one groupBias9Describe any efforts to address potential sources of biasStudy size10Explain how the study size was arrived atContinued on next pageQuantitative variables11Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and whyStatistical methods12(a) Describe all statistical methods, including those used to control for confounding(b) Describe any methods used to examine subgroups and interactions(c) Explain how missing data were addressed(d) Cohort study—If applicable, explain how loss to follow-up was addressedCase-control study—If applicable, explain how matching of cases and controls was addressedCross-sectional study—If applicable, describe analytical methods taking account of sampling strategy(e) Describe any sensitivity analysesResultsParticipants13*(a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed(b) Give reasons for non-participation at each stage(c) Consider use of a flow diagramDescriptive data14*(a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders(b) Indicate number of participants with missing data for each variable of interest(c) Cohort study—Summarise follow-up time (eg, average and total amount)Outcome data15*Cohort study—Report numbers of outcome events or summary measures over timeCase-control study—Report numbers in each exposure category, or summary measures of exposureCross-sectional study—Report numbers of outcome events or summary measuresMain results16(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included(b) Report category boundaries when continuous variables were categorized(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time periodContinued on next pageOther analyses17Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analysesDiscussionKey results18Summarise key results with reference to study objectivesLimitations19Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential biasInterpretation20Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidenceGeneralisability21Discuss the generalisability (external validity) of the study resultsOther informationFunding22Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.